• Home
  • Nanjing Hanxin Pharmaceutical Technology Co., Ltd
16-18
Jun
2026
CPHI & PMEC China 2026
Shanghai New International Expo Center
E2P02
Book a meeting
8-10
Jul
2026
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
G02
Book a meeting
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
2H8
Book a meeting

Nanjing Hanxin Pharmaceutical Technology Co., Ltd

About Nanjing Hanxin Pharmaceutical Technology Co., Ltd

About Us Founded on July 6, 2021, through the restructuring of Amphastar Pharmaceuticals, Inc. (USA) China R&D Center, Nanjing Hanxin Pharmaceuticals Co., Ltd. has a registered capital of CNY 183 million. Leveraging advanced technology platforms and strong R&D capabilities, Hanxin has emerged as a global pharmaceutical Company- engaged in the research, manufacture, and sales of peptides, proteins, and polysaccharides (APIs and finished dosage forms).

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI & PMEC China 2026

    CPHI & PMEC China 2026

    Shanghai New International Expo Center
    16 Jun 2026 - 18 Jun 2026
  • CPHI South East Asia 2026

    CPHI South East Asia 2026

    QSNCC, Bangkok, Thailand
    08 Jul 2026 - 10 Jul 2026
  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • On CPHI since:
    2024
  • Employees:
    250 - 499
Company types
Biopharmaceutical company
CMO/CDMO
Machinery and Equipment Supplier/Manufacturer
Contact info
  • （86）025-52805760
  • Building C5 , No.9 Weidi Road,, Xianlin University Town, Xianlin Street,Qixia, Nanjing, Jiangsu, China
Show contact info Hide contact info